This study is a prospective, randomized controlled clinical trial designed to evaluate the efficacy of transcutaneous electrical stimulation (posterior tibial nerve stimulation, PTNS) in the treatment of overactive bladder (OAB) developing after stroke.
Primary Hypothesis: PTNS therapy will significantly improve OAB symptoms in post-stroke patients compared to standard care/sham stimulation.
Primary Outcome Measure: Change from baseline in Overactive Bladder Symptom Score (OABSS) and/or frequency of urgency episodes as assessed after 12 weeks of treatment."
Female
Age 40 to 70 years
History of ischemic or hemorrhagic stroke at least 6 months before enrollment
Presence of overactive bladder symptoms
Age outside the study range
Pregnancy or breastfeeding
Active urinary tract infection
Neurogenic conditions other than stroke affecting bladder function
Parallel
posterior tibial nerve stimulation, PTNS
Deviceposterior tibial nerve stimulation, PTNS
Change in daily frequency of urgency episodes
Number of urgency episodes per 24 hours recorded in patient bladder diary.
Change in micturition frequency
Average number of micturitions per 24 hours.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
